Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Malignant Melanoma

Free Subscription Articles published in Ophthalmology Retrieve available abstracts of 43 articles: HTML format

Single Articles

June 2020
1. ESPENSEN CA, Kiilgaard JF, Appelt AL, Fog LS, et al
   Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanomas.
   Ophthalmology. 2020 Jun 20. pii: S0161-6420(20)30572.
   PubMed     Abstract available
   
   
   May 2020
2. BOGAARD J, Czaja R, Wirostko WJ
   Metastatic Choroidal Melanoma Treated with Ipilimimab.
   Ophthalmology. 2020;127:600.
   PubMed    
   
   
   April 2020
3. CHUANG K, Vortmeyer A, Liu S
   Conjunctival Fungal Ball Mimicking Melanoma.
   Ophthalmology. 2020;127:534.
   PubMed    
   
   
   
4. JAMPOL LM, Moy CS, Murray TG, Reynolds SM, et al
   The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19.
   Ophthalmology. 2020;127.
   PubMed     Abstract available
   
   
   
5. SALOWE R, O'Brien JM
   The Collaborative Ocular Melanoma Study Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma.
   Ophthalmology. 2020;127.
   PubMed    
   
   
   January 2020
6. MANTA A, Goldberg RA
   Pembrolizumab-Related Enophthalmos.
   Ophthalmology. 2020;127:121.
   PubMed    
   
   
   November 2019
7. ABDEL-RAHMAN MH, Sample KM, Pilarski R, Walsh T, et al
   Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
   Ophthalmology. 2019 Nov 18. pii: S0161-6420(19)32274.
   PubMed     Abstract available
   
   
   
8. LI J, Seider MI
   Pseudomelanoma: Spontaneous Myopic Choroidal Hemorrhage.
   Ophthalmology. 2019;126:1491.
   PubMed    
   
   
   October 2019
9. VAN IPENBURG JA, Gillis Ing AJM, Dorssers LCJ, van den Bosch QCC, et al
   MicroRNA Profiling in Benign and Malignant Conjunctival Melanocytic Lesions.
   Ophthalmology. 2019 Oct 12. pii: S0161-6420(19)32142.
   PubMed    
   
   
   September 2019
10. FRANCIS JH, Berry D, Abramson DH, Barker CA, et al
    Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading.
    Ophthalmology. 2019 Sep 24. pii: S0161-6420(19)32085.
    PubMed     Abstract available
    
    
    April 2019
11. VICHITVEJPAISAL P, Dalvin LA, Mazloumi M, Ewens KG, et al
    Genetic Analysis of Uveal Melanoma in 658 Patients using The Cancer Genome Atlas (TCGA) Classification of Uveal Melanoma as A, B, C & D.
    Ophthalmology. 2019 Apr 23. pii: S0161-6420(19)30611.
    PubMed     Abstract available
    
    
    
12. GROSSNIKLAUS HE
    Understanding Uveal Melanoma Metastasis to the Liver: The Zimmerman Effect and the Zimmerman Hypothesis.
    Ophthalmology. 2019;126:483-487.
    PubMed    
    
    
    
13. ABRAMSON DH, Francis JH
    Pseudomelanoma (with Cataract) in a Child Caused by Amniocentesis.
    Ophthalmology. 2019;126:590.
    PubMed    
    
    
    December 2018
14. MUDHAR HS, Doherty RE, Salvi SM, Currie ZI, et al
    Genetic Profiling of Primary Orbital Melanoma-An Analysis of 6 Cases with Clinico-Pathological Correlation.
    Ophthalmology. 2018 Dec 31. pii: S0161-6420(18)32892.
    PubMed    
    
    
    
15. PAPUDESU C, Reddy SG, Potter HD
    Ocular Metastasis of Cutaneous BRAF Wild-Type Melanoma.
    Ophthalmology. 2018;125:1966.
    PubMed    
    
    
    November 2018
16. SCHOLZ SL, Murali R, Westekemper H, Schadendorf D, et al
    Re: van Poppelen et al.: Genetic background of iris melanomas and iris melanocytic tumors of uncertain malignant potential (Ophthalmology. 2018;125:904-912).
    Ophthalmology. 2018;125:e78-e79.
    PubMed    
    
    
    
17. BEVER GJ, Seider MI
    Two-Toned Lipofuscin in the Same Choroidal Melanoma: Orange versus Gray.
    Ophthalmology. 2018;125:1792.
    PubMed    
    
    
    August 2018
18. JAGER MJ, Brouwer NJ, Esmaeli B
    The Cancer Genome Atlas Project: An Integrated Molecular View of Uveal Melanoma.
    Ophthalmology. 2018;125:1139-1142.
    PubMed    
    
    
    July 2018
19. ROELOFS K, Puttagunta L, Weis E
    Choroidal Melanoma with Overlying Lipofuscin Sediment.
    Ophthalmology. 2018;125:1053.
    PubMed    
    
    
    May 2018
20. DAMATO B
    Predicting Choroidal Melanoma Regression after Brachytherapy.
    Ophthalmology. 2018;125:755-756.
    PubMed    
    
    
    
21. MICIELI JA, Newman NJ, Biousse V
    Retinal Imaging of an Optic Tract Lesion: OCT Angiography of Structural and Functional Defects.
    Ophthalmology. 2018;125:756.
    PubMed    
    
    
    April 2018
22. BAGGER M, Smidt-Nielsen I, Andersen MK, Jensen PK, et al
    Long-Term Metastatic Risk after Biopsy of Posterior Uveal Melanoma.
    Ophthalmology. 2018 Apr 25. pii: S0161-6420(17)33868.
    PubMed     Abstract available
    
    
    
23. AFSHAR AR, Damato BE, Stewart JM, Heimann H, et al
    Re: Reddy et al.: Vitrectomy and vitrector port needle biopsy of choroidal melanoma for gene expression profile testing immediately before brachytherapy. (Ophthalmology. 2017;124:1377-1382).
    Ophthalmology. 2018;125:e28-e29.
    PubMed    
    
    
    
24. RAMAKRISHNAN M, Vora R, Seider MI
    Oculodermal Melanocytosis, Darker Complexion, Choroidal Melanoma: A Missed Clue.
    Ophthalmology. 2018;125:494.
    PubMed    
    
    
    February 2018
25. RASHID M, Heikkonen J, Singh AD, Kivela TT, et al
    Clinical Predictors of Regression of Choroidal Melanomas after Brachytherapy: A Growth Curve Model.
    Ophthalmology. 2018 Feb 27. pii: S0161-6420(17)33252.
    PubMed     Abstract available
    
    
    January 2018
26. VAN POPPELEN NM, Vaarwater J, Mudhar HS, Sisley K, et al
    Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    Ophthalmology. 2018 Jan 19. pii: S0161-6420(17)32844.
    PubMed     Abstract available
    
    
    
27. SHIELDS CL, Di Nicola M, Bekerman VP, Kaliki S, et al
    Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
    Ophthalmology. 2018 Jan 13. pii: S0161-6420(17)32069.
    PubMed     Abstract available
    
    
    November 2017
28. THARIAT J, Rahmi A, Salleron J, Mosci C, et al
    Proton Beam Therapy for Iris Melanomas in 107 Patients.
    Ophthalmology. 2017 Nov 8. pii: S0161-6420(17)32582.
    PubMed     Abstract available
    
    
    
29. LIAO A, Mittal P, Lawson DH, Yang JJ, et al
    Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver.
    Ophthalmology. 2017 Nov 6. pii: S0161-6420(17)32368.
    PubMed     Abstract available
    
    
    October 2017
30. AYRES B, Elner V, Demirci H
    Massive Extraocular Extension of Choroidal Melanoma after Brachytherapy.
    Ophthalmology. 2017;124:1503.
    PubMed    
    
    
    September 2017
31. VALSECCHI ME, Orloff M, Sato R, Chervoneva I, et al
    Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.
    Ophthalmology. 2017 Sep 18. pii: S0161-6420(17)30329.
    PubMed     Abstract available
    
    
    August 2017
32. SZALAI E, Wells JR, Ward L, Grossniklaus HE, et al
    Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Ophthalmology. 2017 Aug 17. pii: S0161-6420(17)31332.
    PubMed     Abstract available
    
    
    June 2017
33. WALTER SD, Cummings TJ, Mruthyunjaya P
    Anterior Chamber Angle Invasion of Iridociliary Melanoma.
    Ophthalmology. 2017;124:842.
    PubMed    
    
    
    May 2017
34. MRUTHYUNJAYA P, Seider MI, Stinnett S, Schefler A, et al
    Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.
    Ophthalmology. 2017 May 23. pii: S0161-6420(16)31873.
    PubMed     Abstract available
    
    
    
35. SHIELDS CL, Say EAT, Hasanreisoglu M, Saktanasate J, et al
    Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture.
    Ophthalmology. 2017 May 7. pii: S0161-6420(17)30398.
    PubMed     Abstract available
    
    
    
36. PELLEGRINI M, Staurenghi G
    Swept-source Optical Coherence Tomography Angiography Imaging in a Case of Uveal Melanoma.
    Ophthalmology. 2017;124:729.
    PubMed    
    
    
    April 2017
37. REDDY DM, Mason LB, Mason JO 3rd, Crosson JN, et al
    Vitrectomy and Vitrector Port Needle Biopsy of Choroidal Melanoma for Gene Expression Profile Testing Immediately before Brachytherapy.
    Ophthalmology. 2017 Apr 28. pii: S0161-6420(16)32000.
    PubMed     Abstract available
    
    
    
38. MOKHTARZADEH A, Harrison AR, Maltry AC
    Malignant Orbital Melanoma Associated with Oculodermal Melanocytosis.
    Ophthalmology. 2017;124:561.
    PubMed    
    
    
    
39. CHAUGULE SS, Finger PT
    Regression Patterns of Iris Melanoma after Palladium-103 (103Pd) Plaque Brachytherapy.
    Ophthalmology. 2017 Apr 1. pii: S0161-6420(17)30011.
    PubMed     Abstract available
    
    
    January 2017
40. SHIELDS CL, Say EA, Hasanreisoglu M, Saktanasate J, et al
    Cytogenetic Abnormalities in Uveal Melanoma Based on Tumor Features and Size in 1059 Patients: The 2016 W. Richard Green Lecture.
    Ophthalmology. 2017 Jan 31. pii: S0161-6420(16)31846.
    PubMed     Abstract available
    
    
    December 2016
41. JACINTO FA, Margo CE
    Neglected Choroidal Melanoma Tracking Along Optic Nerve to Brain.
    Ophthalmology. 2016;123:2488.
    PubMed    
    
    
    
42. YAVUZYIGITOGLU S, Drabarek W, Smit KN, van Poppelen N, et al
    Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma.
    Ophthalmology. 2016 Dec 1. pii: S0161-6420(16)31717.
    PubMed    
    
    
    November 2016
43. SKALET AH, Li Y, Lu CD, Jia Y, et al
    Optical Coherence Tomography Angiography Characteristics of Iris Melanocytic Tumors.
    Ophthalmology. 2016 Nov 14. pii: S0161-6420(16)31328.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: